These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25148523)

  • 1. Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS--a systematic review and meta-analysis of observational studies.
    Wang MD; Gomes J; Cashman NR; Little J; Krewski D
    PLoS One; 2014; 9(8):e105534. PubMed ID: 25148523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis.
    Neuenschwander AG; Thai KK; Figueroa KP; Pulst SM
    JAMA Neurol; 2014 Dec; 71(12):1529-34. PubMed ID: 25285812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis.
    Liu X; Lu M; Tang L; Zhang N; Chui D; Fan D
    Neurobiol Aging; 2013 Sep; 34(9):2236.e5-8. PubMed ID: 23635656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
    Yu Z; Zhu Y; Chen-Plotkin AS; Clay-Falcone D; McCluskey L; Elman L; Kalb RG; Trojanowski JQ; Lee VM; Van Deerlin VM; Gitler AD; Bonini NM
    PLoS One; 2011 Mar; 6(3):e17951. PubMed ID: 21479228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
    Lattante S; Millecamps S; Stevanin G; Rivaud-Péchoux S; Moigneu C; Camuzat A; Da Barroca S; Mundwiller E; Couarch P; Salachas F; Hannequin D; Meininger V; Pasquier F; Seilhean D; Couratier P; Danel-Brunaud V; Bonnet AM; Tranchant C; LeGuern E; Brice A; Le Ber I; Kabashi E;
    Neurology; 2014 Sep; 83(11):990-5. PubMed ID: 25098532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATXN2 trinucleotide repeat length correlates with risk of ALS.
    Sproviero W; Shatunov A; Stahl D; Shoai M; van Rheenen W; Jones AR; Al-Sarraj S; Andersen PM; Bonini NM; Conforti FL; Van Damme P; Daoud H; Del Mar Amador M; Fogh I; Forzan M; Gaastra B; Gellera C; Gitler AD; Hardy J; Fratta P; La Bella V; Le Ber I; Van Langenhove T; Lattante S; Lee YC; Malaspina A; Meininger V; Millecamps S; Orrell R; Rademakers R; Robberecht W; Rouleau G; Ross OA; Salachas F; Sidle K; Smith BN; Soong BW; Sorarù G; Stevanin G; Kabashi E; Troakes C; van Broeckhoven C; Veldink JH; van den Berg LH; Shaw CE; Powell JF; Al-Chalabi A
    Neurobiol Aging; 2017 Mar; 51():178.e1-178.e9. PubMed ID: 28017481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients.
    Tavares de Andrade HM; Cintra VP; de Albuquerque M; Piccinin CC; Bonadia LC; Duarte Couteiro RE; Sabino de Oliveira D; Claudino R; Magno Gonçalves MV; Dourado MET; de Souza LC; Teixeira AL; de Godoy Rousseff Prado L; Tumas V; Bulle Oliveira AS; Nucci A; Lopes-Cendes I; Marques W; França MC
    Neurobiol Aging; 2018 Sep; 69():292.e15-292.e18. PubMed ID: 29934271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling.
    Gellera C; Ticozzi N; Pensato V; Nanetti L; Castucci A; Castellotti B; Lauria G; Taroni F; Silani V; Mariotti C
    Neurobiol Aging; 2012 Aug; 33(8):1847.e15-21. PubMed ID: 22425256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2.
    Tazen S; Figueroa K; Kwan JY; Goldman J; Hunt A; Sampson J; Gutmann L; Pulst SM; Mitsumoto H; Kuo SH
    JAMA Neurol; 2013 Oct; 70(10):1302-4. PubMed ID: 23959108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
    Van Damme P; Veldink JH; van Blitterswijk M; Corveleyn A; van Vught PW; Thijs V; Dubois B; Matthijs G; van den Berg LH; Robberecht W
    Neurology; 2011 Jun; 76(24):2066-72. PubMed ID: 21562247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo mutations in ataxin-2 gene and ALS risk.
    Laffita-Mesa JM; Rodríguez Pupo JM; Moreno Sera R; Vázquez Mojena Y; Kourí V; Laguna-Salvia L; Martínez-Godales M; Valdevila Figueira JA; Bauer PO; Rodríguez-Labrada R; González Zaldívar Y; Paucar M; Svenningsson P; Velázquez Pérez L
    PLoS One; 2013; 8(8):e70560. PubMed ID: 23936447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis.
    Daoud H; Belzil V; Martins S; Sabbagh M; Provencher P; Lacomblez L; Meininger V; Camu W; Dupré N; Dion PA; Rouleau GA
    Arch Neurol; 2011 Jun; 68(6):739-42. PubMed ID: 21670397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
    Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
    Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.
    Kim YE; Oh KW; Noh MY; Park J; Kim HJ; Park JE; Ki CS; Kim SH
    Neurobiol Aging; 2018 Jul; 67():201.e5-201.e8. PubMed ID: 29665996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous ALS and SCA2 associated with an intermediate-length
    Ghahremani Nezhad H; Franklin JP; Alix JJP; Moll T; Pattrick M; Cooper-Knock J; Shanmugarajah P; Beauchamp NJ; Hadjivissiliou M; Paling D; Mcdermott C; Shaw PJ; Jenkins TM
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):579-582. PubMed ID: 33284045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of CACNA1A CAG repeat lengths in patients with familial ALS.
    Brenner D; Müller K; Gastl R; Gorges M; Otto M; Pinkhardt EH; Kassubek J; Weishaupt JH; Ludolph AC
    Neurobiol Aging; 2019 Feb; 74():235.e5-235.e8. PubMed ID: 30342765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate Repeat Expansion in the
    Borrego-Hernández D; Vázquez-Costa JF; Domínguez-Rubio R; Expósito-Blázquez L; Aller E; Padró-Miquel A; García-Casanova P; Colomina MJ; Martín-Arriscado C; Osta R; Cordero-Vázquez P; Esteban-Pérez J; Povedano-Panadés M; García-Redondo A
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate-length polyglutamine in ATXN2 is a possible risk factor among Eastern Chinese patients with amyotrophic lateral sclerosis.
    Lu HP; Gan SR; Chen S; Li HF; Liu ZJ; Ni W; Wang N; Wu ZY
    Neurobiol Aging; 2015 Mar; 36(3):1603.e11-4. PubMed ID: 25457026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating
    Jih KY; Lin KP; Tsai PC; Soong BW; Liao YC; Lee YC
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):442-447. PubMed ID: 33377399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations.
    Naruse H; Matsukawa T; Ishiura H; Mitsui J; Takahashi Y; Takano H; Goto J; Toda T; Tsuji S
    Neurogenetics; 2019 May; 20(2):65-71. PubMed ID: 30847648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.